Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-016835
Filing Date
2024-02-12
Accepted
2024-02-12 21:08:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm245964d2_sc13g.htm SC 13G 39089
  Complete submission text file 0001104659-24-016835.txt   40484
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Subject) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93970 | Film No.: 24622292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12750 HIGH BLUFF DRIVE, SUITE 475 SAN DIEGO CA 92130
Business Address
Lin Yu-Hsin (Filed by) CIK: 0001965964 (see all company filings)

Type: SC 13G